Thermal Biofeedback James Wright Humboldt State University Thermal biofeedback provides feedback on changing skin temperature. Skin temperature is a significant characteristic because it is linked to sympathetic nervous system arousal which affects vasoconstriction and vasodilation and therefore blood flow. Sympathetic nervous system arousal leads to increased vasoconstriction, reducing the blood volume and cooling the skin. Thermal biofeedback is measured by heating a temperature sensitive probe called a "thermistor", made of small pieces of heat-sensitive electrical material encased in electrically insulated material, taped or strapped to the skin. A thermistor only makes thermal contact with the skin, not electrical contact, and will only accept heat from the skin, maintaining the same temperature as the skin to which it is attached, with a slight delay. The probe works by reducing electrical resistance when it increases in temperature and increasing electrical resistance when it cools. Ohm's Law (V=IR) specifies that under constant voltage, increasing the resistance (R) will decrease the current (I) and lowering the resistance increase the current. Therefore, as the thermistor cools, its resistance to electrical current increases and less current will flow through the thermistor. As the thermistor warms, its inherent resistance is lowered and more current flows through it. In this way, information about temperature is sent electrically. While no particular site is superior for the attachment of the thermistors, two principles must be taken into account: 1) surfaces with fewer sweat glands are preferred since sweating can lead to artifacts caused by evaporative cooling and 2) the attachment site should not be artificially warmed by other parts of the body or objects. Other artifacts occur due to temperature changes not resulting from vasoconstriction or vasodilation, such as cool or warm room temperature, breeze, probe contact, "blanketing", and chill. A cool room may, for the same degree of vasoconstriction, lower skin temperature simply because cool air absorbs more heat than warm air. The effect of a cool room may also absorb more heat from the probe in a likewise fashion. A breeze exaggerates the cooling effect since moving air absorbs more heat from the skin than still air and moving air evaporates sweat more quickly than still air. The temperature of the room will set the approximate low temperature limit for the body, since a body cannot cool more than the air surrounding it. This is not an issue except in un-air conditioned rooms in a hot climate. Additionally, differences in temperature effect the circuits of the biofeedback device by slightly increasing or decreasing resistance in the device. If the probe lifts from the skin, lower readings are likely. Furthermore, covering the probe with a hand, clothing or other object, called "blanketing", will give higher readings. Someone entering from a cold outside environment will likely have cold skin, especially extremities, and care must be taken to allow them back to temperature before beginning a thermal biofeedback session. Natural warming occurs with the stopping of activity and especially with rest. Natural warming also takes place after ingestion of caffeine, nicotine, and other chemicals. Body position can also affect sympathetic nervous system arousal and peripheral blood flow. Another important factor in thermal biofeedback is restricting the use of caffeine and nicotine since both are proven strong peripheral vasoconstrictors. Interestingly, psychological studies have shown that caffeine and nicotine are most commonly used by high-anxious people. Thermal biofeedback has found application in the improvement of circulation, relaxation of breathing, migraine headaches, Raynaurd's disease, hypertension, diabetes, and Irritable Bowel Syndrome. Thermal biofeedback has been shown to be quite effective for migraine and mixed headaches (symptoms resemble both migraine and tension headaches). A meta-study of 25 clinical studies of propranolol, the leading migraine medication, and 35 relaxation and thermal biofeedback studies could reveal no consistent advantage for either treatment. Pediatric headaches have been found to respond more effectively to relaxation and biofeedback. In a study by Blanchard (1992) he found that thermal biofeedback "has consistently led to significant improvement and to 67% or better of the samples being clinically improved." He also states "headache reductions noted at the end of treatment have been maintained at follow-up of up to 1 year." Blanchard concludes from his study "TBF (thermal biofeedback) may be the treatment of choice for pediatric migraine." Other studies have shown marked improvement for over 80% of subjects. Conclusions about the effectiveness of thermal biofeedback for menstrual-related migraines are not yet clear. There is at present weak support. More than twenty years has passed since the discovery of the association between reduced migraine headaches and hand warming. A threshold for migraine reduction seems to be 96?F. In another study by Blanchard (Blanchard, et al., 1983) found that 63% of subjects who achieved hand warming above this threshold were successful in migraine pain reduction. Raynaud's disease symptoms involve spasm of the arterioles and small arteries in the digits of the hands and feet and tri- phasic skin color changes. Occasionally, symptoms effect the nose and tongue, yet rarely involve the thumb. Spasm duration may be from minutes to hours. Cold exposure is the usual stimulus for spasms, but emotional and other psychological events may trigger them. Vasospastic attacks may be lessened significantly with peripheral vasoconstriction. The study by Friedman (Friedman, 1987) employed a cold stimulus as a challenge with thermal biofeedback. There was 66.8% reduction in symptoms in the thermal feedback group, as opposed to a 32.6% reduction without thermal biofeedback, and a 92.5% reduction in symptoms for the group employing the cold stimulus challenge and thermal biofeedback. These results were maintained for 3 years following treatment. Thermal biofeedback can be used as a breathing feedback system to enhance relaxed breathing by attaching the thermistor to the scalp apex. Normal levels of CO2 increases cerebral blood flow. It has been asserted that this gives an index of blood flow in the brain. Patients trained with thermal biofeedback were observed to reduce their blood pressure. Additionally, supine and standing norepinephrine levels decreased with biofeedback trained reduction in blood pressure. In another study incorporating thermal biofeedback with blood pressure monitoring, EMG, and breath rate, 58% of patients were able to eliminate medication and an additional 35% of patients reduced hypertension medication by half. A third study by McGrady (1994) had 49% of thermal biofeedback patients lowering mean arterial pressure by at least 5mm Hg. Significant decreases in measures of anxiety and plasma aldosterone also were observed. The rationale for the use of thermal biofeedback is that increased sympathetic nervous system activity commonly observed during stress constricts the blood vessels in the skin. The decreased blood flow results in lower temperatures. In contrast, decreased sympathetic activation results in less vasoconstriction. Therefore, as patients warm their hands they are decreasing neurally mediated vasoconstriction. However, Friedman (1991) has shown that increases in temperarture mediated by thermal biofeedback by non-hypertensives depends on non neural factors whose identities have yet to be determined. Thermal biofeedback may be useful in maintaining circulation in the hands and feet, although data on this application is incomplete. A study by Bailey, (Bailey, et al., 1990), reported a patient with little temperature sensation was still able to increase hand and finger temperature via thermal biofeedback. A study by Guthrie (1983) treated diabetes mellitus type I patients with a combination of thermal biofeedback and EMG (more common for diabetes). Four of seven patients achieved a decrease in units of insulin required to maintain glucose levels. Thermal biofeedback has also been used in the treatment of Irritable Bowel Syndrome, with mixed results, to help reduce autonomic arousal and disregulation. While early results showed promise, larger samples of patients showed clinical improvement similar to that of placebo. However, those that underwent biofeedback and relaxation training had treatment gains that lasted up to four years, which could not be said of the placebo group. Thermal biofeedback has shown a proven track record for attenuating symptoms in a variety of disorders and further applications are continually being examined and evaluated. References Schwartz 1995 Biofeedback: A Practioner'S Guide. The Guilford Press. New York, New York Blanchard, E.B. 1992 Psychological treatment of benign headache disorders. Journal of Consulting and Clinical Psycology, 60(4), 537-551 Blanchard, E.B., Andrasik, F., Neff, D.F., Arena, J.G., Ahles T.A., Jurish, S.E., Pallmeyer, T.P., Saunders, N.L., Teders, S.J., Barron, K.D., and Rodickok, L.D. 1983 Psychophysiological responses as predictors of response to behavioral treatment of chronic headache. Behavior Therapy, 14(3), 357-374 Freedman, R.R 1987 Long-term effectiveness of behavioral treatments for Raynaurd's disease. Behavior Therapy, 18, 387-399 McGrady, A.V. 1994 Effects of group relaxation training and thermal biofeedback on blood pressure and related psycophysiological variables in essential hypertension. Biofeedback and Self-Regulation, 19(1), 51-66 Freedman, R.R. 1991 Physiological mechanisms of temperature biofeedback. Biofeedback and Self-Regulation, 16, 95-115 Guthrie, D., Moeller, T., and Guthrie R. 1983 Biofeedback and its application to the stabilization and control of diabetes mellitus. American Journal of Clinical Biofeedback 6(2), 82-87Return to the Project Table of Contents Go back to the beginning
Copyright © 2003, Dr. John M. Morgan, All rights reserved -
This page last edited April 23, 2003
If you have any feedback for the author, E-mail me